Heterogeneity of drug target expression among meta...[Clin Cancer Res. 2008]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

1: Clin Cancer Res. 2008 Jun 15;14(12):3643-5. Links

Heterogeneity of drug target expression among metastatic lesions: lessons from a breast cancer autopsy program.

Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA. steegp@mail.nih.gov

PMID: 18559575 [PubMed - indexed for MEDLINE]

PMCID: PMC2692037

ReviewRole of ErbB4 in breast cancer.
J Mammary Gland Biol Neoplasia. 2008 Jun; 13(2):259-68. Epub 2008 May 3.

[J Mammary Gland Biol Neoplasia. 2008]
ReviewAn update on the biology of cancer stem cells in breast cancer.
Clin Transl Oncol. 2008 Dec; 10(12):786-93.

[Clin Transl Oncol. 2008]
NCI launches an innovative design for a breast cancer clinical trial.
J Natl Cancer Inst. 2006 Sep 6; 98(17):1178-9.

[J Natl Cancer Inst. 2006]
Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy.
J Clin Oncol. 2008 Aug 1; 26(22):3660-2.

[J Clin Oncol. 2008]
ReviewWhat can breast cancer molecular sub-classification add to conventional diagnostic tools?
Ann Oncol. 2007 Jul; 18 Suppl 9:ix33-6.

[Ann Oncol. 2007]
» See reviews... | » See all...

Your browsing activity is empty.

Activity recording is turned off.

Display Show